Serenova A/S: Financial statements 2015
CVR: 30532228
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
Serenova A/S (CVR 30532228) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 153,000 and a net result of DKK -33,853,000 compared with DKK -22,151,000 the year before. That is a decrease of 80.5% compared with the year before. The profit margin was -22,126.1%. Equity in the 2015 report amounted to DKK 61,193,000. The solvency ratio was 83.4%.
- Revenue
- DKK 153,000
- Profit/Loss
- DKK -33,853,000
- Equity
- DKK 61,193,000
- Total Assets
- DKK 73,391,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | 153 t. | - | -33.9 mio. | 61.2 mio. | - |
| 2014 | 786 t. | - | -22.2 mio. | 33.7 mio. | - |
| 2012 | - | -77 t. | -333 t. | 10.3 mio. | 2 |
Official annual report
How creditworthy is Serenova A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
Serenova A/S has published its annual report for 2014. Revenue came to DKK 786,000, and the net result was DKK -22,151,000.
As of April 30, 2015, Joseph Donald deBethizy has joined the board of directors of Serenova A/S.
As of April 30, 2015, Poul Tørring has left the board of directors of Serenova A/S.
About Serenova A/S
Serenova A/S is a Danish company of the type Aktieselskab based in Solrød Strand, founded in 2008. The company is in liquidation. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named SERENDEX PHARMACEUTICALS A/S and SERENDEX A/S. The management consists of Michael Aslo-Petersen. The company is owned by Sorana Holding A/S. The company has 0 employees (2016). In 2025, the company reported a gross profit of DKK -167,993 and a net result of DKK 38,663,045 compared with DKK -24,273,688 the year before. Equity in the 2025 report amounted to DKK 105,405,408.